Literature DB >> 26848320

Ichthyosis linearis circumflexa in a child. Response to narrowband UVB therapy.

Ralfi Singer1, Mehmet Çopur1, Ece Nur Yüksel1, Emek Kocatürk1, Selma Şengiz Erhan2.   

Abstract

BACKGROUND: Ichthyosis linearis circumflexa is a rare form of ichthyosis characterized by polycyclic and annular lesions which are bordered by a double-edged scale. Netherton syndrome is a genodermatosis in which ichthyosis linearis circumflexa is accompanied by characteristic hair shaft abnormalities and atopic diathesis. Different treatment modalities such as emmolients, keratolytics, calcipotriene, topical corticosteroids, topical calcineurin inhibitors, systemic retinoids, phototherapy and photochemotherapy have been used with variable results. Topical therapies may result in considerable absorption because of the defective barrier function in ichthyosis linearis circumflexa/Netherton syndrome. MAIN OBSERVATION: A 12-year-old patient diagnosed as ichthyosis linearis circumflexa demonstrated considerable improvement with narrowband UVB phototherapy at the end of 30 sessions.
CONCLUSION: Short-term narrowband-UVB may an effective treatment option in patients with ichthyosis linearis circumflexa/Netherton syndrome.

Entities:  

Keywords:  Netherton syndrome; UV; ichthyosis; phototherapy; treatment; trichorrhexis invaginata

Year:  2015        PMID: 26848320      PMCID: PMC4733355          DOI: 10.3315/jdcr.2015.1214

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  7 in total

1.  Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome.

Authors:  S Chavanas; C Bodemer; A Rochat; D Hamel-Teillac; M Ali; A D Irvine; J L Bonafé; J Wilkinson; A Taïeb; Y Barrandon; J I Harper; Y de Prost; A Hovnanian
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  UVA1 phototherapy of Netherton syndrome.

Authors:  Rossana Capezzera; Marina Venturini; Denise Bianchi; Cristina Zane; Piergiacomo Calzavara-Pinton
Journal:  Acta Derm Venereol       Date:  2004       Impact factor: 4.437

3.  Narrowband UVB phototherapy as a novel treatment for Netherton syndrome.

Authors:  Edidiong Celestine Ntuen Kaminska; Bernhard Ortel; Vishakha Sharma; Sarah L Stein
Journal:  Photodermatol Photoimmunol Photomed       Date:  2012-06       Impact factor: 3.135

4.  Clearance of ichthyosis linearis circumflexa with balneophototherapy.

Authors:  T Gambichler; E Senger; P Altmeyer; K Hoffmann
Journal:  J Eur Acad Dermatol Venereol       Date:  2000-09       Impact factor: 6.166

5.  Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome.

Authors:  A Allen; E Siegfried; R Silverman; M L Williams; P M Elias; S K Szabo; N J Korman
Journal:  Arch Dermatol       Date:  2001-06

6.  Successful therapy of ichthyosis linearis circumflexa with PUVA.

Authors:  M Manabe; T Yoshiike; M Negi; H Ogawa
Journal:  J Am Acad Dermatol       Date:  1983-06       Impact factor: 11.527

7.  Narrowband ultraviolet B phototherapy associated with improvement in Netherton syndrome.

Authors:  I Maatouk; R Moutran; R Tomb
Journal:  Clin Exp Dermatol       Date:  2012-06       Impact factor: 3.470

  7 in total
  2 in total

Review 1.  Netherton Syndrome in Children: Management and Future Perspectives.

Authors:  Federica Barbati; Mattia Giovannini; Teresa Oranges; Lorenzo Lodi; Simona Barni; Elio Novembre; Ermanno Baldo; Mario Cristofolini; Stefano Stagi; Silvia Ricci; Francesca Mori; Cesare Filippeschi; Chiara Azzari; Giuseppe Indolfi
Journal:  Front Pediatr       Date:  2021-05-10       Impact factor: 3.418

2.  Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency.

Authors:  Kira Stuvel; Jorn J Heeringa; Virgil A S H Dalm; Ruud W J Meijers; Els van Hoffen; Susan A M Gerritsen; Menno C van Zelm; Suzanne G M A Pasmans
Journal:  Allergy       Date:  2020-02-21       Impact factor: 13.146

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.